Co-Authors
This is a "connection" page, showing publications co-authored by FREDRICK B HAGEMEISTER and TIMOTHY J MCDONNELL.
Connection Strength
0.125
-
A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL. Blood Adv. 2023 04 11; 7(7):1137-1145.
Score: 0.058
-
Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma. J Clin Oncol. 2023 02 01; 41(4):745-755.
Score: 0.056
-
Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma. Blood. 1999 May 01; 93(9):3081-7.
Score: 0.011